This invention generally relates to intravascular medical device systems that navigable through body vessels of a human subject. More particularly, this invention relates to delivery systems and delivery members for delivering and deploying an implantable medical device to a target location of a body vessel and methods of using the same.
The use of catheter delivery systems for positioning and deploying therapeutic devices, such as dilation balloons, stents, and embolic coils, in the vasculature of the human body has become a standard procedure for treating endovascular diseases. It has been found that such devices are particularly useful in treating areas where traditional operational procedures are impossible or pose a great risk to the patient, for example in the treatment of aneurysms in cranial blood vessels.
Procedures typically involve inserting a guide catheter (also referred to as a delivery catheter) into the vasculature of a patient and guiding it through the vasculature to a treatment site. A vascular occlusion device, such as an embolic coil or braid, can be attached to an implant engagement/deployment system (referred to herein equivalently as an “engagement system” or “deployment system”) at a distal end a of a delivery member (e.g. micro-catheter) which pushes the vascular occlusion device through the guide catheter and out of the distal end of the guide catheter into the treatment site. Example delivery members and engagement/deployment systems are described in U.S. patent application Ser. No. 15/850,993 and U.S. patent application Ser. No. 15/964,857 each incorporated herein by reference.
Applicant recognizes a need for alternative methods, devices, and systems to provide an implant delivery member and implant engagement system for delivering and deploying vascular occlusion devices.
An example system for deploying an intrasaccular implant to occlude an aneurysm can include the intrasaccular implant, a pusher tube, a securing wire, and a pull wire. The intrasaccular implant, pusher tube, securing wire, and pull wire can be sized to fit within a microcatheter.
The intrasaccular implant can include a securing ring thereon. The securing ring can include a proximal surface and an opening having an inner diameter. The opening of the securing ring can include a substantially circular shape defined by the inner diameter. The intrasaccular implant can include a braided mesh that is self-expandable upon exiting the microcatheter. The intrasaccular implant can include a cavity therein. The intrasaccular implant can include a substantially tubular braided mesh body. The body can include a first aperture oriented at a first region of the body and a second aperture oriented at a second region of the body. The securing ring can be disposed on the first region of the body approximate the first aperture. The second aperture can correspond to a free open end of the substantially tubular braided mesh body
The pusher tube can include a distal surface sized to engage the proximal surface of the securing ring and positioned to face the proximal surface of the securing ring. A distal region of the pusher tube can be flexible. The distal region of the pusher tube that is flexible can include a flexibility array. The pusher tube can include a compressibly resilient portion at a distal region of the pusher tube.
The securing wire can extend through a lumen of the pusher tube and the opening of the securing ring. The securing wire can include an extended securing member thereon positioned on an opposite side of the securing ring in relation to the pusher tube. The securing member can include a securing member diameter measuring less than the inner diameter of the opening of the securing ring. The securing member can include a substantially spherical shape defined by the securing member diameter. The securing wire can be movable to pass the securing member through the opening in the securing ring when the pull wire has exited the opening of the securing ring. The securing wire can be coupled to an inner surface of the pusher tube by an attachment portion. The securing member can be disposed in the cavity of the implant.
The pull wire can extend through the lumen of the pusher tube and the opening of the securing ring. The pull wire can include a pull wire diameter such that the sum of the securing member diameter and the pull wire diameter measures greater than the inner diameter of the opening of the securing ring. The pull wire can include a substantially circularly shaped perimeter defined by the pull wire diameter. The pull wire can be movable to exit the opening of the securing ring while the securing wire is extended through the ring. A portion of the pull wire can be disposed in the cavity of the implant.
If the pusher tube includes a compressibly resilient portion, the securing wire can hold the compressibly resilient portion in compression. The securing member of the securing wire can be engaged to the securing ring, and an elongated portion of the securing wire can be affixed to the pusher tube in a proximal direction in relation to the compressibly resilient portion. Tension in the portion of the securing member extending from a coupling of the securing wire to the inner surface of the pusher tube to the engagement of the securing member to the securing ring can hold the compressibly resilient distal region in compression. The compressibly resilient distal region can be configured to expand and push the securing ring over the securing member when the pull wire has exited the securing ring.
An example method for deploying an intrasaccular implant in an aneurysm can include one or more of the following steps presented in no particular order. The example method can include additional steps as would be appreciated and understood by a person of ordinary skill in the art. The example method can be performed using an example system as disclosed herein, a variation thereof, or an alternative thereto as would be appreciated and understood by a person of ordinary skill in the art. A system including a microcatheter, a pusher tube, a securing wire a pull wire, and an intrasaccular implant can be selected. The system can be selected such that the securing wire includes a radially extending securing member and the implant includes a securing ring.
The system can be positioned in a delivery configuration such that pusher tube, securing wire, pull wire, and implant are positioned within the microcatheter, the pusher tube is in the proximal direction in relation to the securing ring, the securing wire extends through the securing ring and pusher tube such that the securing member is positioned in the distal direction from the securing ring, and the pull wire extends through the pusher tube and the securing ring.
The implant can be moved in the distal direction through the microcatheter by moving the pusher tube, pull wire, and securing wire in the distal direction.
The intrasaccular implant can be extended into a sac of the aneurysm. The step of extending the intrasaccular implant into the sac of the aneurysm further can include allowing the implant to self-expand in the sac.
The pull wire can be retracted in the proximal direction to free the pull wire from the securing ring. Retracting the securing wire from the securing ring further can include retracting the pusher tube in the proximal direction while the securing wire is coupled to the pusher tube. The securing wire can be retracted from the securing ring by moving the securing member through the securing ring when the pull wire is free from the securing ring.
Attachment of the implant to the pusher tube can be maintained by engaging the securing member to a distal surface of the engagement ring while engaging a distal surface of the pusher tube to a proximal surface of the engagement ring. Maintaining attachment of the implant to the pusher tube further can include inhibiting the securing member from passing through the securing ring by maintaining the pull wire to extend within the securing ring.
An example system for treating an aneurysm can include a microcatheter, a pusher tube, an intrasaccular implant, a securing wire, and a pull wire.
The intrasaccular implant can include a securing ring. The securing ring can have an inner diameter.
The pusher tube can be oriented within the microcatheter. The pusher tube can include a compressibly resilient distal region and an inner surface. The pusher tube can include distal surface at the distal region of the pusher tube, sized to engage a proximal surface of the securing ring.
The securing wire can include an extended securing member and an attachment portion. The securing member can include a securing member diameter measuring less than the inner diameter of the securing ring. The securing member can be positioned in the distal direction in relation to the securing ring. The attachment portion of the securing wire can be coupled to the inner surface of the pusher tube in the proximal direction in relation to the compressibly resilient distal region of the pusher tube. The securing member of the securing wire can be engaged to the securing ring.
The pull wire can be oriented in the pusher tube, extend through the securing ring. The pull wire can include a pull wire dimension less than the inner diameter of the securing ring. The sum of the securing member diameter and the pull wire diameter can be greater than the inner diameter of the securing ring.
The pull wire can be movable to exit the securing ring while the securing wire is extending through the securing ring. The compressibly resilient distal region of the pusher tube can be compressed due to tension in the securing wire over a portion of the securing wire extending from the securing ring to the coupling of the attachment portion to the inner surface of the pusher tube. The compressibly resilient distal region can be configured to expand and push the securing ring over the securing member when the pull wire has exited the securing ring.
Another example intravascular treatment system can include an implant, a pull wire, and a securing wire.
The implant can include an embolic body and a securing ring affixed to the body. The securing ring can include a proximal surface, a distal surface, and an opening including an inner diameter.
The pull wire having a pull wire diameter can extend through the opening of the securing ring. The pull wire can be translatable in the proximal direction to exit the opening in the securing ring.
The securing wire can extend through the opening of the securing ring. The securing wire can have an extended securing member thereon and an extended pusher member thereon. The securing member can be positioned in the distal direction in relation to the distal surface of the securing ring. The pusher member can be positioned in the proximal direction in relation to the proximal surface of the securing ring. The securing member can have a diameter dimensioned such that the sum of the pull wire diameter and securing member diameter is greater than the inner diameter of the securing ring. The pushing member can have a diameter dimensioned such that the sum of the pull wire diameter and the pushing member diameter is greater than the inner diameter of the securing member. The securing member can be movable to engage the distal surface of the securing ring when the securing wire is pulled proximally. The pusher member can be movable to engage the proximal surface of the securing ring when the securing wire is pushed distally. The securing member and pusher member are each inhibited from moving through the opening in the securing ring due to the extension of the pull wire through the securing ring. The securing wire can be translatable in the proximal direction to exit the opening in the securing ring when the pull wire is absent from the opening.
The above and further aspects of this invention are further discussed with reference to the following description in conjunction with the accompanying drawings, in which like numerals indicate like structural elements and features in various figures. The drawings are not necessarily to scale, emphasis instead being placed upon illustrating principles of the invention. The figures depict one or more implementations of the inventive devices, by way of example only, not by way of limitation.
As used herein, the terms “about” or “approximately” for any numerical values or ranges indicate a suitable dimensional tolerance that allows the part or collection of components to function for its intended purpose as described herein. More specifically, “about” or “approximately” may refer to the range of values ±20% of the recited value, e.g. “about 90%” may refer to the range of values from 71% to 99%.
As used herein, the terms “tubular” and “tube” are not limited to a structure that is a right cylinder or strictly circumferential in cross-section or of a uniform cross-section throughout its length. For example, the tubular structure or system is generally illustrated as a substantially right cylindrical structure. However, the tubular system may have a tapered outer surface, a curved outer surface, and/or a partially flat outer surface without departing from the scope of the present disclosure.
As used herein, the term “wire” includes solid core and hollow elongated tubular structures.
A system is disclosed herein that can be used to push, track, deploy, position, and detach an implant at an aneurysm. The system can include an engagement/deployment system and an embolic implant. The embolic implant can be a braid that is mechanically attached to the engagement/deployment system, pushed by a delivery pusher (e.g. hypotube) of the engagement/deployment system to a treatment site using a microcatheter, wherein the microcatheter is pre-placed at the level of the aneurysm neck and is used to track the device to the treatment site/lesion. The delivery pusher extends from the proximal to the distal end of the delivery microcatheter such that a physician can manipulate a proximal end of the delivery pusher to push the distal end of the delivery pusher out of the distal end of the microcatheter.
The engagement/deployment system includes a two wire securing system to secure the implant to the distal end of the hypotube (delivery pusher). One of the wires can have a bump, extension, or other such securing feature thereon (referred to herein as an “securing wire”) and the other can have a substantially uniform circumference (referred to herein as a “pull wire”). The pull wire can be elongated to extend out of the patient or otherwise be available for manipulation during treatment such that the pull wire can be pulled proximally in relation to the securing wire.
The delivery pusher can include a hypotube (metal or polymer) having with a flexible distal portion. Flexibility of the distal portion of the hypotube can be attained by cutting a spiral or an interrupted cut through the wall of the hypotube. Additionally, or alternatively, the pusher can include an extended pushing member formed on the securing wire in a proximal direction in relation to the securing member on the securing wire. In examples where the pusher includes a hypotube, the securing wire can be tethered to the pusher tube. In examples where the pusher lacks a hypotube and includes a securing member on the securing wire, the securing wire can have an elongated portion that can be pulled proximally independent of the pull wire.
The intrasaccular implant can have an annular ring attached to its proximal end to connect the engagement/deployment system to the implant. To attach the implant to the engagement/deployment system, the securing feature of the securing wire is inserted into the annular ring of the implant first, then the pull wire is inserted into the annular ring of the implant. This secures the implant to the pusher as the inner diameter of the annular ring is smaller than the diameter of the pull wire plus the diameter of the securing feature.
To deploy the implant the pull wire can be retracted, thereby enabling the securing feature to separate from the implant as the diameter of the securing feature is smaller than the inner diameter of the annular ring. Once the pull wire is retracted the pusher tube can be retracted separating the implant from the engagement/deployment system.
The implant 102 includes a securing ring 112 having a proximal surface SA2, a distal surface SA3, and an opening 113. The pusher tube 106 can have a lumen 107 therethrough and a distal surface SA1 sized to engage the proximal surface SA2 of the securing ring 112. The distal surface SA1 of the pusher tube 106 can be positioned to face the proximal surface SA2 of the securing ring 112. The securing wire 120 includes a securing member 114 thereon. When the implant 102 is attached to the pusher tube 106, the securing wire 120 and the pull wire 116 each extend through the lumen 107 of the pusher tube 106 and the opening 113 of the securing ring 112, and the securing member 114 is positioned on the opposite side of the securing ring 112 in relation to the pusher tube 106. The pull wire 120 and securing member 114 can be sized such that when placed side-by-side the securing member is inhibited from passing through an opening of the securing ring 112. The body 108 of the implant 102 can include a cavity 110 that is sized such that the securing member 114 and a distal portion of the pull wire 116 can fit therein when the implant 102 is secured to the pusher tube 106.
Referring collectively to
The securing wire 120 can include an elongated portion 121 extending through the securing ring 112. The elongated portion 121 of the securing wire 120 is smaller in diameter than the securing member 114 such that the securing member 114 extends radially outwardly from the elongated portion 121. The elongated portion 121 can be sufficiently small in diameter to allow the securing wire 120 and pull wire 116 to both be positioned to extend through the opening 113 of the securing ring 112.
The pusher can include an elongated hypotube 106. The hypotube can extend through vasculature 40 of a patient such that the hypotube 106 can be manipulated at its proximal end to position the implant 102 at a treatment site during treatment. The distal surface SA1 of the pusher 106 can be sized to engage the proximal surface SA2 of the securing ring 112 and positioned to face the proximal surface SA2 of the implant 102. The pull wire 116 can extend through the lumen of the hypotube 106 and can be manipulated at the proximal end of the hypotube to move the distal end of the pull wire 116 proximally in relation to the distal portion 122 of the hypotube 106.
Once detached, the implant 102 can be difficult to retract or otherwise reposition compared to the ease with which the implant 102 can be retracted and repositioned prior to detachment. The pusher tube 106, pull wire 116, and securing wire 120 can be retracted through the microcatheter 104. The microcatheter 104 can remain in place to provide a conduit for delivery of additional treatment devices, or the microcatheter 104 can be retracted together with the pusher tube 106, pull wire 116, and securing wire 120.
The first region 126 represents the region closest to the engagement/deployment system when the implant 102a is positioned within the aneurysm 50. If portions of the implant 102a are retracted into the microcatheter 104 for redeployment, the first region 126 enters the microcatheter before the second region 128.
The tube 106c can further include a flexible region 122a, 122b as illustrated in
As illustrated, the pull wire 116 and securing wire 220 extend through the opening 113 of the securing ring 112. As illustrated in
When the securing wire 220 is pushed distally, the pusher member 222 moves to engage the proximal surface SA2 of the securing ring 112.
The descriptions contained herein are examples of embodiments of the invention and are not intended in any way to limit the scope of the invention. As described herein, the invention contemplates many variations and modifications of the intravascular implant system, including alternative materials for component parts, and/or alternative geometries of component parts as would be apparent to those having ordinary skill in the art to which this invention relates and are intended to be within the scope of the claims which follow.
Number | Name | Date | Kind |
---|---|---|---|
3429408 | Maker et al. | Feb 1969 | A |
5108407 | Geremia et al. | Apr 1992 | A |
5122136 | Guglielmi et al. | Jun 1992 | A |
5250071 | Palermo | Oct 1993 | A |
5263964 | Purdy | Nov 1993 | A |
5334210 | Gianturco | Aug 1994 | A |
5350397 | Palermo et al. | Sep 1994 | A |
5382259 | Phelps et al. | Jan 1995 | A |
5484409 | Atkinson et al. | Jan 1996 | A |
5569221 | Houser et al. | Oct 1996 | A |
5899935 | Ding | May 1999 | A |
5925059 | Palermo et al. | Jul 1999 | A |
6113622 | Hieshima | Sep 2000 | A |
6203547 | Nguyen et al. | Mar 2001 | B1 |
6391037 | Greenhalgh | May 2002 | B1 |
6454780 | Wallace | Sep 2002 | B1 |
6506204 | Mazzocchi | Jan 2003 | B2 |
6561988 | Turturro et al. | May 2003 | B1 |
7367987 | Balgobin et al. | May 2008 | B2 |
7371251 | Mitelberg et al. | May 2008 | B2 |
7371252 | Balgobin et al. | May 2008 | B2 |
7377932 | Mitelberg et al. | May 2008 | B2 |
7708754 | Balgobin et al. | May 2010 | B2 |
7708755 | Davis, III et al. | May 2010 | B2 |
7799052 | Balgobin et al. | Sep 2010 | B2 |
7811305 | Balgobin et al. | Oct 2010 | B2 |
7819891 | Balgobin et al. | Oct 2010 | B2 |
7819892 | Balgobin et al. | Oct 2010 | B2 |
7901444 | Slazas | Mar 2011 | B2 |
7985238 | Balgobin et al. | Jul 2011 | B2 |
8062325 | Mitelberg et al. | Nov 2011 | B2 |
8333796 | Tompkins et al. | Dec 2012 | B2 |
9155540 | Lorenzo | Oct 2015 | B2 |
9232992 | Heidner | Jan 2016 | B2 |
9314326 | Wallace et al. | Apr 2016 | B2 |
9532792 | Galdonik et al. | Jan 2017 | B2 |
9532873 | Kelley | Jan 2017 | B2 |
9533344 | Monetti et al. | Jan 2017 | B2 |
9539011 | Chen et al. | Jan 2017 | B2 |
9539022 | Bowman | Jan 2017 | B2 |
9539122 | Burke et al. | Jan 2017 | B2 |
9539382 | Nelson | Jan 2017 | B2 |
9549830 | Bruszewski et al. | Jan 2017 | B2 |
9554805 | Tompkins et al. | Jan 2017 | B2 |
9561125 | Bowman et al. | Feb 2017 | B2 |
9572982 | Burnes et al. | Feb 2017 | B2 |
9579484 | Barnell | Feb 2017 | B2 |
9585642 | Dinsmoor et al. | Mar 2017 | B2 |
9615832 | Bose et al. | Apr 2017 | B2 |
9615951 | Bennett et al. | Apr 2017 | B2 |
9622753 | Cox | Apr 2017 | B2 |
9636115 | Henry et al. | May 2017 | B2 |
9636439 | Chu et al. | May 2017 | B2 |
9642675 | Werneth et al. | May 2017 | B2 |
9655633 | Leynov et al. | May 2017 | B2 |
9655645 | Staunton | May 2017 | B2 |
9655989 | Cruise et al. | May 2017 | B2 |
9662120 | Lagodzki et al. | May 2017 | B2 |
9662129 | Galdonik et al. | May 2017 | B2 |
9662238 | Dwork et al. | May 2017 | B2 |
9662425 | Lilja et al. | May 2017 | B2 |
9668898 | Wong | Jun 2017 | B2 |
9675477 | Thompson | Jun 2017 | B2 |
9675782 | Connolly | Jun 2017 | B2 |
9676022 | Ensign et al. | Jun 2017 | B2 |
9692557 | Murphy | Jun 2017 | B2 |
9693852 | Lam et al. | Jul 2017 | B2 |
9700262 | Janik et al. | Jul 2017 | B2 |
9700399 | Acosta-Acevedo | Jul 2017 | B2 |
9717421 | Griswold et al. | Aug 2017 | B2 |
9717500 | Tieu et al. | Aug 2017 | B2 |
9717502 | Teoh et al. | Aug 2017 | B2 |
9724103 | Cruise et al. | Aug 2017 | B2 |
9724526 | Strother et al. | Aug 2017 | B2 |
9750565 | Bloom et al. | Sep 2017 | B2 |
9757260 | Greenan | Sep 2017 | B2 |
9764111 | Gulachenski | Sep 2017 | B2 |
9770251 | Bowman et al. | Sep 2017 | B2 |
9770577 | Li et al. | Sep 2017 | B2 |
9775621 | Tompkins et al. | Oct 2017 | B2 |
9775706 | Paterson et al. | Oct 2017 | B2 |
9775732 | Khenansho | Oct 2017 | B2 |
9788800 | Mayoras, Jr. | Oct 2017 | B2 |
9795391 | Saatchi et al. | Oct 2017 | B2 |
9801980 | Karino et al. | Oct 2017 | B2 |
9808599 | Bowman et al. | Nov 2017 | B2 |
9833252 | Sepetka et al. | Dec 2017 | B2 |
9833604 | Lam et al. | Dec 2017 | B2 |
9833625 | Waldhauser et al. | Dec 2017 | B2 |
9918718 | Lorenzo | Mar 2018 | B2 |
10285710 | Lorenzo et al. | May 2019 | B2 |
10292851 | Gorochow | May 2019 | B2 |
10420563 | Hebert et al. | Sep 2019 | B2 |
10517604 | Bowman et al. | Dec 2019 | B2 |
10668258 | Calhoun et al. | Jun 2020 | B1 |
10806402 | Cadieu et al. | Oct 2020 | B2 |
10806461 | Lorenzo | Oct 2020 | B2 |
20010049519 | Holman et al. | Dec 2001 | A1 |
20020072705 | Vrba et al. | Jun 2002 | A1 |
20020165569 | Ramzipoor et al. | Nov 2002 | A1 |
20030009208 | Snyder et al. | Jan 2003 | A1 |
20040034363 | Wilson et al. | Feb 2004 | A1 |
20040059367 | Davis et al. | Mar 2004 | A1 |
20040087964 | Diaz et al. | May 2004 | A1 |
20060025801 | Lulo | Feb 2006 | A1 |
20060064151 | Guterman | Mar 2006 | A1 |
20060100687 | Fahey et al. | May 2006 | A1 |
20060116711 | Elliott et al. | Jun 2006 | A1 |
20060116714 | Sepetka | Jun 2006 | A1 |
20060135986 | Wallace | Jun 2006 | A1 |
20060206139 | Tekulve | Sep 2006 | A1 |
20060247677 | Cheng | Nov 2006 | A1 |
20060276824 | Mitelberg et al. | Dec 2006 | A1 |
20060276825 | Mitelberg et al. | Dec 2006 | A1 |
20060276826 | Mitelberg et al. | Dec 2006 | A1 |
20060276827 | Mitelberg et al. | Dec 2006 | A1 |
20060276830 | Balgobin et al. | Dec 2006 | A1 |
20060276833 | Balgobin et al. | Dec 2006 | A1 |
20070010850 | Balgobin et al. | Jan 2007 | A1 |
20070055302 | Henry | Mar 2007 | A1 |
20070083132 | Sharrow | Apr 2007 | A1 |
20070233168 | Davis et al. | Oct 2007 | A1 |
20070270903 | Davis, III et al. | Nov 2007 | A1 |
20080027561 | Mitelberg et al. | Jan 2008 | A1 |
20080045997 | Balgobin et al. | Feb 2008 | A1 |
20080097462 | Mitelberg | Apr 2008 | A1 |
20080281350 | Sepetka | Nov 2008 | A1 |
20080300616 | Que | Dec 2008 | A1 |
20080306503 | Que et al. | Dec 2008 | A1 |
20090062726 | Ford et al. | Mar 2009 | A1 |
20090312748 | Johnson et al. | Dec 2009 | A1 |
20100114017 | Lenker et al. | May 2010 | A1 |
20100324649 | Mattsson | Dec 2010 | A1 |
20110202085 | Loganathan | Aug 2011 | A1 |
20110295303 | Freudenthal | Dec 2011 | A1 |
20120035707 | Mitelberg et al. | Feb 2012 | A1 |
20120041472 | Tan et al. | Feb 2012 | A1 |
20120283768 | Cox et al. | Nov 2012 | A1 |
20130066413 | Jin et al. | Mar 2013 | A1 |
20140058435 | Jones et al. | Feb 2014 | A1 |
20140135812 | Divino et al. | May 2014 | A1 |
20140200607 | Sepetka et al. | Jul 2014 | A1 |
20140277084 | Mirigian et al. | Sep 2014 | A1 |
20140277085 | Mirigian et al. | Sep 2014 | A1 |
20140277092 | Teoh et al. | Sep 2014 | A1 |
20140277093 | Guo et al. | Sep 2014 | A1 |
20150005808 | Chouinard et al. | Jan 2015 | A1 |
20150025562 | Dinh et al. | Jan 2015 | A1 |
20150182227 | Le et al. | Jul 2015 | A1 |
20150230802 | Lagodzki et al. | Aug 2015 | A1 |
20150335333 | Jones | Nov 2015 | A1 |
20160008003 | Kleshinski | Jan 2016 | A1 |
20160022275 | Garza | Jan 2016 | A1 |
20160022445 | Ruvalcaba | Jan 2016 | A1 |
20160157869 | Elgard et al. | Jun 2016 | A1 |
20160228125 | Pederson, Jr. et al. | Aug 2016 | A1 |
20160310304 | Mialhe | Oct 2016 | A1 |
20160346508 | Williams et al. | Dec 2016 | A1 |
20170007264 | Cruise et al. | Jan 2017 | A1 |
20170007265 | Guo et al. | Jan 2017 | A1 |
20170020670 | Murray et al. | Jan 2017 | A1 |
20170020700 | Bienvenu et al. | Jan 2017 | A1 |
20170027640 | Kunis et al. | Feb 2017 | A1 |
20170027692 | Bonhoeffer et al. | Feb 2017 | A1 |
20170027725 | Argentine | Feb 2017 | A1 |
20170035436 | Morita | Feb 2017 | A1 |
20170035567 | Duffy | Feb 2017 | A1 |
20170042548 | Lam | Feb 2017 | A1 |
20170049596 | Schabert | Feb 2017 | A1 |
20170071737 | Kelley | Mar 2017 | A1 |
20170072452 | Monetti et al. | Mar 2017 | A1 |
20170079671 | Morero et al. | Mar 2017 | A1 |
20170079680 | Bowman | Mar 2017 | A1 |
20170079766 | Wang et al. | Mar 2017 | A1 |
20170079767 | Leon-Yip | Mar 2017 | A1 |
20170079812 | Lam et al. | Mar 2017 | A1 |
20170079817 | Sepetka et al. | Mar 2017 | A1 |
20170079819 | Pung et al. | Mar 2017 | A1 |
20170079820 | Lam et al. | Mar 2017 | A1 |
20170086851 | Wallace et al. | Mar 2017 | A1 |
20170086996 | Peterson et al. | Mar 2017 | A1 |
20170095258 | Tassoni | Apr 2017 | A1 |
20170095259 | Tompkins et al. | Apr 2017 | A1 |
20170100126 | Bowman et al. | Apr 2017 | A1 |
20170100141 | Morero et al. | Apr 2017 | A1 |
20170100143 | Granfield | Apr 2017 | A1 |
20170100183 | Iaizzo et al. | Apr 2017 | A1 |
20170113023 | Steingisser et al. | Apr 2017 | A1 |
20170147765 | Mehta | May 2017 | A1 |
20170151032 | Loisel | Jun 2017 | A1 |
20170165062 | Rothstein | Jun 2017 | A1 |
20170165065 | Rothstein et al. | Jun 2017 | A1 |
20170165454 | Tuohy et al. | Jun 2017 | A1 |
20170172581 | Bose et al. | Jun 2017 | A1 |
20170172766 | Vong et al. | Jun 2017 | A1 |
20170172772 | Khenansho | Jun 2017 | A1 |
20170189033 | Sepetka et al. | Jul 2017 | A1 |
20170189035 | Porter | Jul 2017 | A1 |
20170215902 | Leynov et al. | Aug 2017 | A1 |
20170216484 | Cruise et al. | Aug 2017 | A1 |
20170224350 | Shimizu et al. | Aug 2017 | A1 |
20170224355 | Bowman et al. | Aug 2017 | A1 |
20170224467 | Piccagli et al. | Aug 2017 | A1 |
20170224511 | Dwork et al. | Aug 2017 | A1 |
20170224953 | Tran et al. | Aug 2017 | A1 |
20170231749 | Perkins et al. | Aug 2017 | A1 |
20170245864 | Franano et al. | Aug 2017 | A1 |
20170245885 | Lenker | Aug 2017 | A1 |
20170252064 | Staunton | Sep 2017 | A1 |
20170258476 | Hayakawa et al. | Sep 2017 | A1 |
20170265983 | Lam et al. | Sep 2017 | A1 |
20170281192 | Tieu et al. | Oct 2017 | A1 |
20170281331 | Perkins et al. | Oct 2017 | A1 |
20170281344 | Costello | Oct 2017 | A1 |
20170281909 | Northrop et al. | Oct 2017 | A1 |
20170281912 | Melder et al. | Oct 2017 | A1 |
20170290593 | Cruise et al. | Oct 2017 | A1 |
20170290654 | Sethna | Oct 2017 | A1 |
20170296324 | Argentine | Oct 2017 | A1 |
20170296325 | Marrocco et al. | Oct 2017 | A1 |
20170303939 | Greenhalgh et al. | Oct 2017 | A1 |
20170303942 | Greenhalgh et al. | Oct 2017 | A1 |
20170303947 | Greenhalgh et al. | Oct 2017 | A1 |
20170303948 | Wallace et al. | Oct 2017 | A1 |
20170304041 | Argentine | Oct 2017 | A1 |
20170304097 | Corwin et al. | Oct 2017 | A1 |
20170304595 | Nagasrinivasa et al. | Oct 2017 | A1 |
20170312109 | Le | Nov 2017 | A1 |
20170312484 | Shipley et al. | Nov 2017 | A1 |
20170316561 | Helm et al. | Nov 2017 | A1 |
20170319826 | Bowman et al. | Nov 2017 | A1 |
20170333228 | Orth et al. | Nov 2017 | A1 |
20170333236 | Greenan | Nov 2017 | A1 |
20170333678 | Bowman et al. | Nov 2017 | A1 |
20170340383 | Bloom et al. | Nov 2017 | A1 |
20170348014 | Wallace et al. | Dec 2017 | A1 |
20170348514 | Guyon et al. | Dec 2017 | A1 |
20170367712 | Johnson et al. | Dec 2017 | A1 |
20180028779 | von Oepen et al. | Feb 2018 | A1 |
20180036508 | Ozasa | Feb 2018 | A1 |
20180228493 | Aguilar | Aug 2018 | A1 |
20180250150 | Majercak et al. | Sep 2018 | A1 |
20180280667 | Keren | Oct 2018 | A1 |
20180325706 | Hebert et al. | Nov 2018 | A1 |
20190159784 | Sananes | May 2019 | A1 |
20190192162 | Lorenzo | Jun 2019 | A1 |
20190255290 | Snyder et al. | Aug 2019 | A1 |
20190314033 | Mirigian | Oct 2019 | A1 |
20190328398 | Lorenzo | Oct 2019 | A1 |
20200138448 | Dasnurkar | May 2020 | A1 |
20200187951 | Blumenstyk | Jun 2020 | A1 |
20210001082 | Lorenzo et al. | Jan 2021 | A1 |
Number | Date | Country |
---|---|---|
1985244 | Oct 2008 | EP |
2498691 | Sep 2012 | EP |
3092956 | Nov 2016 | EP |
3501427 | Jun 2019 | EP |
2006-334408 | Dec 2006 | JP |
2012-523943 | Oct 2012 | JP |
2013-78584 | May 2013 | JP |
WO 2009132045 | Oct 2009 | WO |
WO 2012158152 | Nov 2012 | WO |
WO 2017066386 | Apr 2017 | WO |
WO 2018022186 | Feb 2018 | WO |
Entry |
---|
Extended European Search Report issued in European Patent Application No. 21 15 6857 dated Jun. 22, 2021, pp. 1-9. |
Extended European Search Report issued in corresponding European Patent Application No. 20 21 2970 dated May 28, 2021, pp. 1-7. |
Number | Date | Country | |
---|---|---|---|
20210251635 A1 | Aug 2021 | US |